Structural Organization and Dynamic Characteristics of the Binding Site for Conformational Rearrangement Inhibitors in Hemagglutinins from H3N2 and H7N9 Influenza Viruses

被引:0
作者
D. D. Podshivalov
E. M. Kirilin
S. I. Konnov
V. K. Švedas
机构
[1] Lomonosov Moscow State University,
[2] Faculty of Bioengineering and Bioinformatics,undefined
[3] Belozersky Institute of Physico-Chemical Biology,undefined
[4] Lomonosov Moscow State University,undefined
来源
Biochemistry (Moscow) | 2020年 / 85卷
关键词
hemagglutinin; influenza virus; molecular dynamics; metadynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:499 / 506
页数:7
相关论文
共 94 条
[1]  
Skehel J. J.(2000)Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Ann. Rev. Biochem. 69 531-569
[2]  
Wiley D. C.(2014)Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories Curr. Opin. Virol. 8 85-89
[3]  
Hensley S. E.(2009)Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift Science 326 734-736
[4]  
Hensley S. E.(2015)Alterations in hemagglutinin receptor-binding specificity accompany the emergence of highly pathogenic avian influenza viruses J. Virol. 89 5395-5405
[5]  
Das S. R.(2013)Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity Cell 153 1475-1485
[6]  
Bailey A. L.(2019)Evolution of pandemic influenza virus A(H1N1)pdm09 in 2009-2016: dynamics of receptor specificity of the first hemagglutinin subunit (НA1) Vopr. Virusol. 64 63-72
[7]  
Schmidt L. M.(2008)Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion Proc. Natl. Acad. Sci. USA 105 17736-17741
[8]  
Hickman H. D.(2018)A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin Proc. Natl. Acad. Sci. USA 115 4240-4245
[9]  
Jayaraman A.(2017)Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol Proc. Natl. Acad. Sci. USA 114 206-214
[10]  
Viswanathan K.(2016)The 340-cavity in neuraminidase provides new opportunities for influenza drug development: a molecular dynamics simulation study Biochem. Biophys. Res. Commun. 470 130-136